Home › Funds › Siren, L.L.C. › SLN

Siren, L.L.C. position in SLN

Silence Therapeutics PLC · Health Care

Siren, L.L.C. reported holding 2,887,867 shares of SLN (Silence Therapeutics PLC) in its Q3 2026 13F filing — a position valued at US$31.6M, representing 0.75% of its reported portfolio and ranking #33 among its reported holdings. Siren, L.L.C. has disclosed SLN holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)2.89M sh
Reported value held$31.56M
Portfolio Weight0.75%
First reportedQ3 2024
Last changeReduce
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Siren, L.L.C.'s SLN position evolved

Siren, L.L.C. first disclosed a stake in SLN in Q3 2024 at 2,831,770 shares (US$51.5M). Across 9 filings, Siren, L.L.C. increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 2,887,867 shares valued at US$31.6M — a reduction of -423,571 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2024 2.83M $51.48M New
Q4 2024 2.83M $19.48M Hold
Q1 2025 2.79M $7.87M Reduce
Q2 2025 2.91M $16.89M Add
Q3 2025 2.91M $15.11M Hold
Q4 2025 2.91M $17.70M Hold
Q1 2026 2.91M $15.34M Hold
Q2 2026 3.31M $36.36M Add
Q3 2026 2.89M $31.56M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SLN and 13F data

SLN (Silence Therapeutics PLC) is a Health Care company. 35 other funds we track also report a position in SLN — the largest reported positions include TCG Crossover Management, LLC (US$33.3M), Redmile Group, LLC (US$23.8M), Nantahala Capital Management, LLC (US$14.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SLN

All SLN fund holders →

FAQ

How long has Siren, L.L.C. held SLN?

Siren, L.L.C. has disclosed SLN holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Siren, L.L.C.'s current position in SLN?

As of Q3 2026, Siren, L.L.C. holds 2.89M shares of SLN (Silence Therapeutics PLC), valued at $31.56M, representing 0.75% of its reported portfolio and ranking #33.

Has Siren, L.L.C. been buying or selling SLN?

In the latest 13F filing (Q3 2026), Siren, L.L.C. reduced its position in SLN.

Which other funds hold SLN?

Other major institutional holders of SLN include TCG Crossover Management, LLC, Redmile Group, LLC, Nantahala Capital Management, LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.